Volume 13, Issue 2 pp. 175-181
Original Article

Symptomatic overlap between irritable bowel syndrome and microscopic colitis

David Limsui MD

David Limsui MD

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Search for more papers by this author
Darrell S. Pardi MD

Corresponding Author

Darrell S. Pardi MD

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

200 First Street, SW, Rochester, Minnesota 55905Search for more papers by this author
Michael Camilleri MD

Michael Camilleri MD

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Search for more papers by this author
Edward V. Loftus Jr. MD

Edward V. Loftus Jr. MD

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Search for more papers by this author
Patricia P. Kammer CCRP

Patricia P. Kammer CCRP

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Search for more papers by this author
William J. Tremaine MD

William J. Tremaine MD

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Search for more papers by this author
William J. Sandborn MD

William J. Sandborn MD

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota

Search for more papers by this author
First published: 19 December 2006
Citations: 12

Presented at 2005 Digestive Disease Week meeting, Chicago, IL and published in abstract form (Gastroenterology 2005;128:A331).

Abstract

Background: Microscopic colitis is diagnosed on the basis of histologic criteria, and irritable bowel syndrome (IBS) is diagnosed by symptom-based criteria. There has been little investigation into the symptomatic overlap between these conditions. Our aim was to assess the prevalence of symptoms of irritable bowel syndrome in a population-based cohort of patients with microscopic colitis.

Methods: The Rochester Epidemiology Project (REP), a medical records linkage system providing all health care data for the defined population of Olmsted County, Minnesota, was used to identify all county residents with a diagnosis of microscopic colitis between 1985 and 2001. The medical records of these individuals were reviewed to ascertain symptoms consistent with Rome, Rome II, and Manning criteria for irritable bowel syndrome.

Results: One hundred thirty-one cases of microscopic colitis were identified. Median age at diagnosis was 68 years (range, 24–95); 71% were women. Sixty-nine (53%) and 73 (56%) met Rome and Rome II criteria for irritable bowel syndrome, respectively. Fifty-four (41%) had three or more Manning criteria. Forty-three (33%) had previously been diagnosed with irritable bowel syndrome.

Conclusions: In this population-based cohort of histologically confirmed microscopic colitis, approximately one-half met symptom-based criteria for the diagnosis of irritable bowel syndrome. The clinical symptom-based criteria for irritable bowel syndrome are not specific enough to rule out the diagnosis of microscopic colitis. Therefore, patients with suspected diarrhea-predominant irritable bowel syndrome should undergo biopsies of the colon to investigate for possible microscopic colitis if symptoms are not well controlled by antidiarrheal therapy.

(Inflamm Bowel Dis 2006)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.